Heart failure with preserved ejection fraction: a clinical dilemma.
about
Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular HealthNew Insights in the Diagnosis and Treatment of Heart FailureMyocardial hypertrophy and its role in heart failure with preserved ejection fractionHeart failure as a general pandemic in AsiaAddressing the Heterogeneity of Heart Failure in Future Randomized Trials.Who are patients classified within the new terminology of heart failure from the 2016 ESC guidelines?Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.Pro-B-type natriuretic peptide-1-108 processing and degradation in human heart failure.Heart failure with preserved ejection fraction in women: the Dutch Queen of Hearts program.Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in miceMineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis.Automated Classification of Severity in Cardiac Dyssynchrony Merging Clinical Data and Mechanical DescriptorsLeft Ventricular Diastolic Dysfunction in Ischemic Stroke: Functional and Vascular Outcomes.Newest additions to heart failure treatment.Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction.Heart failure with preserved ejection fraction: uncertainties and dilemmas.Candidate biomarkers in heart failure with reduced and preserved ejection fraction.Cardiac and Hemodynamic Benefits: Mode of Action of Ivabradine in Heart Failure.Sacubitril/valsartan (LCZ696) for the treatment of heart failure.Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure.Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?Validation of heart failure diagnosis registered in primary care records in two primary care centres in Barcelona (Spain) and factors related. A cross-sectional study.Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.Left atrium: the last bulwark before overt heart failure.New and Emerging Therapies and Targets: Beta-3 Agonists.Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia.Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction.Novel plasma and imaging biomarkers in heart failure with preserved ejection fraction.Abnormal Remodeling of Subcutaneous Small Arteries Is Associated With Early Diastolic Impairment in Metabolic Syndrome.New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction.Cardiovascular mechanics in the early stages of pulmonary hypertension: a computational study.Beneficial Effects of Positive Airway Pressure Therapy for Sleep-Disordered Breathing in Heart Failure Patients With Preserved Left Ventricular Ejection Fraction.Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine?Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.Fibrosis assessment by integrated backscatter and its relationship with longitudinal deformation and diastolic function in heart failure with preserved ejection fraction.Association between sleep-disordered breathing and arterial stiffness in heart failure patients with reduced or preserved ejection fraction.
P2860
Q26744466-82A480CC-A690-4417-8D03-DBC97E52A319Q26774884-CDAB48DD-B424-467F-85EE-68A088A6420AQ26800076-96AF62AC-9A2F-41A5-9399-BC8B1B668656Q26801810-095548D8-E310-434C-80E7-F2AA90A9F756Q30234708-4FCB9C0C-AF7D-448A-A89C-083BC14A450EQ33577412-9080F6C7-052B-4BA2-8B4B-E5D5024FB4EDQ34487487-D0FC635A-3C9E-475B-8088-B9F21EAB256DQ35002194-E442E32A-3965-4755-9E36-87E068A7938DQ35044611-C74D5316-2833-49A8-81C5-1DA23981B94BQ35164124-7160C45F-2BE0-41F0-B912-F171DF98848EQ35261976-FCC19037-95C1-454D-A20E-898F095F23D4Q36208986-3F91A9B3-B167-477B-9012-5E594593CCB3Q36324748-3C4ADCC5-926A-4269-B349-2658141431D6Q36991930-0AB9F94D-100F-46AC-B1D3-86AF1C2031CFQ38225739-07745EAF-CAB5-4810-9371-C6D33D74282FQ38440130-0AD527EC-117B-421C-87C7-02A591418375Q38529003-CE76504D-7EDF-4338-B0E3-34BB561813EEQ38572500-5E5DB8E1-A9F7-4719-B846-16A1138AAC51Q38621386-3A57149E-E216-4B35-A13E-CEE79AAE3693Q38661061-CEB0F561-3CFF-42CD-A49C-47D5078BD3FEQ38737757-40E113DD-AEEF-4AF9-B99A-E97B681DA660Q38746041-5FBD531E-3CB8-4536-861A-8999DEC228B1Q38855301-CEF3BC55-75F2-4C59-A99F-DB5BECB5B954Q38859108-F62CA278-48AA-4E72-9095-685916CDC62CQ38959952-C73C86E3-244C-4B8A-8BB7-CACB1270A12DQ39016287-9633A9A5-C6FB-4BFA-924A-47E74D2B6C65Q39062830-CA2A4106-4B92-4E34-9EAE-33D5626673D6Q40084324-DCBC6E6C-B690-42A2-BE96-5854E0122772Q40617892-368A3ECF-4665-471E-B782-FCE1D97E51D2Q40963394-DDD4553B-A8DE-47E2-84E0-609F8CC2DBF1Q41165835-FB7C6EFD-2B0E-44DD-9445-6F58190B9B1DQ41701494-3C8DAD11-DE78-4609-9C55-8EE7F8FEE008Q46874079-A4FDF237-5F50-40CA-A37C-9FAF30F57B3DQ47726582-EB12B375-BC2B-4571-A5E2-874C704441FDQ47755673-1690C0E0-2B00-492D-8729-90E489EDFE7EQ47973663-5B9C105F-48D0-4D35-8F37-A8967604066FQ48247164-6569D138-9A6A-4D71-BFFC-332A95E7235FQ48268685-F4D44226-B253-4F32-B4A0-3EF432330104Q48619525-4F7668C6-0E1A-40D3-938A-68B0AC2CC0DEQ49821972-1DE34F52-CD53-4648-81E0-89E589636ED3
P2860
Heart failure with preserved ejection fraction: a clinical dilemma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Heart failure with preserved ejection fraction: a clinical dilemma.
@en
type
label
Heart failure with preserved ejection fraction: a clinical dilemma.
@en
prefLabel
Heart failure with preserved ejection fraction: a clinical dilemma.
@en
P2860
P356
P1476
Heart failure with preserved ejection fraction: a clinical dilemma.
@en
P2093
Carolyn S P Lam
P2860
P304
P356
10.1093/EURHEARTJ/EHU067
P577
2014-03-11T00:00:00Z